Earl Martin Douglas Allogene Therapeutics, Inc. (ALLO) insider trading activity

ALLO Quotes by TradingView

Earl Martin Douglas is SVP, General Counsel of Allogene Therapeutics, Inc.. Currently has a direct ownership of 587,848 shares of ALLO, which is worth approximately $964,070. The most recent transaction as insider was on Feb 03, 2025, when has been sold 6,404 shares (Common Stock) at a price of $1.71 per share, resulting in proceeds of $10,950. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 588K
30.83% 3M change
23.07% 12M change
Total Value Held $964,070

Earl Martin Douglas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2025
SELL
Open market or private sale
$10,950 $1.71 p/Share
6,404 Reduced 1.08%
587,848 Common Stock
Jan 24 2025
BUY
Grant, award, or other acquisition
-
144,928 Added 19.61%
594,252 Common Stock
Aug 21 2024
SELL
Payment of exercise price or tax liability
$78,984 $2.79 p/Share
28,310 Reduced 5.93%
449,324 Common Stock
Jan 25 2024
BUY
Grant, award, or other acquisition
-
41,800 Added 8.05%
477,634 Common Stock
Aug 14 2023
BUY
Grant, award, or other acquisition
-
435,834 Added 50.0%
435,834 Common Stock
EMD

Earl Martin Douglas

SVP, General Counsel
South San Francisco,

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

News

Receive news related to Allogene Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALLO